You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-positive Breast Cancer Trial in Amsterdam (Trastuzumab deruxtecan)

Not yet recruiting
  • HER2-positive Breast Cancer
  • Trastuzumab deruxtecan
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
Aug 7, 2023

Metastatic Breast Cancer Trial (Meritup oral solution)

Not yet recruiting
  • Metastatic Breast Cancer
  • Meritup oral solution
  • (no location specified)
Nov 29, 2023

Metastatic Breast Cancer Trial in Al Madinah (Palbociclib)

Not yet recruiting
  • Metastatic Breast Cancer
  • Al Madīnah, AL, Saudi Arabia
    Asmaa Imam Ahmed
Oct 8, 2023

Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

Not yet recruiting
  • Estrogen-receptor-positive Breast Cancer
  • +3 more
  • elacestrant, palbociclib, abemaciclib, ribociclib
  • Chicago, Illinois
    Northwestern University
Sep 25, 2023

Breast Cancer, Metastatic Breast Cancer, Breast Tumor Trial in Port Jefferson Station (SV-BR-1-GM, Cyclophosphamide, Interferon

Not yet recruiting
  • Breast Cancer
  • +4 more
  • SV-BR-1-GM
  • +4 more
  • Port Jefferson Station, New York
    New York Cancers & Blood Specialists
Oct 2, 2023

Discovering Factors in Metastatic Breast Cancer Patients'

Not yet recruiting
  • Metastatic Breast Cancer
    • (no location specified)
    Feb 25, 2023

    Breast Cancer, Metastatic Breast Cancer, Radiation Therapy Complication Trial in Seoul

    Recruiting
    • Breast Cancer
    • +2 more
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Jun 8, 2023

      Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)

      Not yet recruiting
      • Metastatic Breast Cancer
      • Lobular Breast Carcinoma
      • Blood Specimen
      • San Francisco, California
        University of California, San Francisco
      Jul 19, 2023

      Breast Cancer, Lipid Cell; Tumor, Nutrition Related Cancer Trial in Roma (Lipidomic analysis for breast cancer patients)

      Not yet recruiting
      • Breast Cancer
      • +3 more
      • Lipidomic analysis for breast cancer patients
      • Roma, Italy
        Fondazione Policlinico Universitario A. Gemelli IRCCS
      Sep 4, 2023

      Metastatic Breast Cancer Trial (BDC-1001, Pertuzumab)

      Not yet recruiting
      • Metastatic Breast Cancer
      • (no location specified)
      Jul 12, 2023

      Using a Blood Test to Monitor Metastatic Breast Cancer Treatment

      Not yet recruiting
      • Metastatic Breast Cancer
        • Kingston, Ontario, Canada
        • +1 more
        Mar 27, 2023

        HER2-PositiveRecurrent or Metastatic Breast Cancer Trial (SHR-A1811 Injection, SHR-A1811 Injection ; Pertuzumab Injection,

        Not yet recruiting
        • HER2-PositiveRecurrent or Metastatic Breast Cancer
        • SHR-A1811 Injection
        • +2 more
        • (no location specified)
        Sep 21, 2023

        Adverse Events, Produced by Antibodies Conjugates, on Quality of

        Not yet recruiting
        • Metastatic Breast Cancer
          • Aviano, Pordenone, Italy
          • +2 more
          Oct 24, 2023

          Breast Cancer Trial in Xi'an (metronomic oral vinorelbine plus anlotinib)

          Recruiting
          • Breast Cancer
          • metronomic oral vinorelbine plus anlotinib
          • Xi'an, Shaanxi, China
            Xi'an International Medical Center Hospital
          Aug 27, 2023

          Breast Cancer Trial in New York (Multicomponent Adherence Intervention)

          Recruiting
          • Breast Cancer
          • Multicomponent Adherence Intervention
          • New York, New York
            Columbia University Medical Center
          Nov 6, 2023

          DESTINY Breast Respond HER2-low Europe

          Not yet recruiting
          • Unresectable Breast Cancer
          • +2 more
          • Trastuzumab deruxtecan
          • (no location specified)
          Jul 6, 2023

          Germline and Somatic Pathogenic Variants in de Novo Metastatic

          Active, not recruiting
          • Metastatic Breast Cancer
          • NGS in blood and Formalin-Fixed Paraffin-Embedded (FFPE) tissue
          • Athens, Greece
            Evangelia Moirogiorgou
          Mar 7, 2023

          Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

          Recruiting
          • Metastatic Breast Cancer
          • +3 more
          • Shanghai, Shanghai, China
            Fudan University Shanghai Cancer Center
          Sep 26, 2023

          Metastatic Breast Cancer Trial in Philadelphia (Adapted Intimacy Enhancement, Intimacy Facts and Resources)

          Recruiting
          • Metastatic Breast Cancer
          • Adapted Intimacy Enhancement
          • Intimacy Facts and Resources
          • Philadelphia, Pennsylvania
            Fox Chase Cancer Center
          Dec 5, 2022

          Ribociclib in Combination With Hormonal Therapy in HR+/HER2-

          Not yet recruiting
          • Breast Cancer
          • ribociclib
          • (no location specified)
          Oct 10, 2023

          Advanced or Metastatic Breast Cancer Trial in Paris (Milademetan, Patient Reported Outcomes (PROs) and Health-Related Quality of

          Not yet recruiting
          • Advanced or Metastatic Breast Cancer
          • Milademetan
          • Patient Reported Outcomes (PROs) and Health-Related Quality of Life (HRQOL)
          • Paris, France
            Institut Curie
          Jun 27, 2023

          Liver Metastases, Breast Cancer Trial in Leuven, Amsterdam (Quiremspheres™)

          Recruiting
          • Liver Metastases
          • Breast Cancer
          • Quiremspheres™
          • Leuven, Vlaams-Brabant, Belgium
          • +1 more
          Nov 16, 2023

          Breast Cancer Trial (SHR-A1811, Capecitabine/Eribulin/Gemcitabine/Paclitaxel/Nab-paclitaxel)

          Not yet recruiting
          • Breast Cancer
          • (no location specified)
          Apr 3, 2023

          Breast Cancer Trial (Disitamab Vedotin+Anlotinib)

          Not yet recruiting
          • Breast Cancer
          • Disitamab Vedotin+Anlotinib
          • (no location specified)
          Aug 14, 2023

          Identify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia

          Not yet recruiting
          • Identify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia
          • identify biomarkers
          • (no location specified)
          May 13, 2023